Plus Therapeutics Inc.
1.24
0.06 (5.08%)
At close: Jan 15, 2025, 2:40 PM

Plus Therapeutics Inc. Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Sep 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Grant Revenue 1.46M 1.28M 1.24M 506.00K 151.00K 73.00K
Grant Revenue Growth +13.84% +3.15% +145.06% +235.10% +106.85% n/a

Revenue by Geography

Quarter Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015
Americas Revenue 293.00K 345.00K 936.00K 787.00K
Americas Revenue Growth -15.07% -63.14% +18.93% n/a
Asia Pacific Revenue 50.00K 76.00K 62.00K 2.39M
Asia Pacific Revenue Growth -34.21% +22.58% -97.41% n/a
E M E A Revenue 270.00K 344.00K 379.00K n/a
E M E A Revenue Growth -21.51% -9.23% n/a n/a
Japan Revenue 2.06M 1.92M 3.28M n/a
Japan Revenue Growth +6.96% -41.32% n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 2.40M 2.20M 2.03M 2.20M 2.00M 1.92M 2.24M 3.58M 2.22M 2.29M 2.14M 2.04M 1.99M 1.47M 1.35M 2.30M 1.06M 1.43M 1.62M 1.67M 1.17M 972.00K 1.94M 1.50M 1.94M 1.99M 2.92M 2.13M 2.63M 3.38M 3.05M 2.81M 2.83M 3.22M 3.32M 2.71M 2.94M 3.45M 3.34M
Selling, General, and Administrative Revenue Growth +8.81% +8.68% -7.74% +9.96% +3.85% -14.22% -37.43% +61.34% -2.93% +6.91% +4.85% +2.61% +35.47% +8.65% -41.19% +116.89% -25.82% -11.68% -3.23% +42.91% +20.37% -49.79% +28.89% -22.54% -2.76% -31.76% +37.05% -18.78% -22.38% +10.99% +8.51% -0.74% -12.06% -3.13% +22.68% -7.80% -14.82% +3.27% n/a
Research and Development Revenue 2.86M 2.77M 2.76M 2.79M 2.49M 1.42M 2.98M 2.14M 2.94M 2.83M 1.78M 1.85M 1.49M 1.11M 1.13M 1.10M 336.00K 1.11M 941.00K 1.73M 921.00K 1.29M 1.85M 2.26M 1.92M 1.95M 2.50M 2.39M 3.00M 2.99M 4.97M 2.86M 3.96M 5.25M 4.13M 4.63M 4.35M 6.05M 3.96M
Research and Development Revenue Growth +3.07% +0.36% -1.11% +12.07% +75.56% -52.40% +39.52% -27.40% +4.03% +58.60% -3.46% +24.01% +34.81% -1.86% +2.83% +226.19% -69.68% +17.75% -45.58% +87.73% -28.55% -30.17% -18.17% +17.75% -1.79% -21.93% +4.39% -20.31% +0.40% -39.86% +73.83% -27.73% -24.53% +27.14% -10.84% +6.36% -28.04% +52.61% n/a